PLYMOUTH, Minnesota — Lumen Biomedical, which makes catheters to break and clear blockages in the veins, is raising $4 million, according to a filing with the Securities and Exchange Commission.
Lumen this year has struck exclusive distribution agreements for its two devices: the FiberNet System, which breaks and then captures blockages in the carotid artery in the head and neck, and the Xtract Catheter which can be guided around a vein to remove blockages including clots throughout the body. Invetec started distributing FiberNet in January (pdf) and Volcano started distributing Xtract in May.
Both devices have Food and Drug Administration and European approvals. They were approved by the FDA last year.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
